OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targets and cross-reactivity of human T cell recognition of common cold coronaviruses
Alison Tarke, Yun Zhang, Nils Methot, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101088-101088
Open Access | Times Cited: 25

Showing 25 citing articles:

T cell immune memory after covid-19 and vaccination
Lulu Wang, Alexander R. Nicols, Lance Turtle, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000468-e000468
Open Access | Times Cited: 25

In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms
S. Cankat, M. U. Demael, Leo Swadling
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 103-118
Open Access | Times Cited: 24

One Health Approach to the Computational Design of a Lipoprotein-Based Multi-Epitope Vaccine Against Human and Livestock Tuberculosis
Robert Adamu Shey, Gordon Takop Nchanji, Tangan Yanick Aqua Stong, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1587-1587
Open Access

Discordant Outcomes of SARS-CoV-2 Infection in Household Contacts
Ye‐Ji Lee, Alison Tarke, Tertuliano Alves Pereira Neto, et al.
(2025)
Closed Access

Pre-existing SARS-2-specific T cells are predicted to cross-recognize BA.2.86
Alessandro Sette, John Sidney, Alba Grifoni
Cell Host & Microbe (2023) Vol. 32, Iss. 1, pp. 19-24.e2
Closed Access | Times Cited: 14

Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults
Taraz Samandari, Joshua Ongalo, Kimberly D. McCarthy, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 13

Targets of influenza Human T cell response are mostly conserved in H5N1
John Sidney, A-Reum Kim, Rory D. de Vries, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3

T cell control of SARS-CoV-2: When, which, and where?
Mariana O. Diniz, Mala K. Maini, Leo Swadling
Seminars in Immunology (2023) Vol. 70, pp. 101828-101828
Open Access | Times Cited: 8

The impact of SARS-CoV-2 spike mutation on peptide presentation is HLA allomorph-specific
You Min Ahn, Janesha C. Maddumage, Emma J. Grant, et al.
Current Research in Structural Biology (2024) Vol. 7, pp. 100148-100148
Open Access | Times Cited: 2

SARS-CoV-2-specific T cell responses: a comparative analysis between QuantiFERON SARS-CoV-2, T-SPOT.COVID, and an in-house Omicron ELISpot
Willem A. Mak, Wendy Visser, Johannes G.M. Koeleman, et al.
Journal of Virological Methods (2024) Vol. 327, pp. 114949-114949
Open Access | Times Cited: 1

SARS‐CoV‐2 reinfection broadens the antibody responses and promotes the phenotypic differentiation of virus‐specific memory T cells in adolescents
Xin‐Jing Zhao, Xiaolin Liu, Hong‐Jing Gu, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Open Access | Times Cited: 1

T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination
Samuele Notarbartolo
Vaccines (2024) Vol. 12, Iss. 10, pp. 1126-1126
Open Access | Times Cited: 1

Targets of influenza human T-cell response are mostly conserved in H5N1
John Sidney, A-Reum Kim, Rory D. de Vries, et al.
mBio (2024)
Open Access | Times Cited: 1

An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination
Ricardo da Silva Antunes, Alba Grifoni, April Frazier, et al.
International Immunology (2023) Vol. 35, Iss. 8, pp. 353-359
Open Access | Times Cited: 3

Multiantigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses
Jeroen van Bergen, Marcel Camps, Iris N. Pardieck, et al.
JCI Insight (2023) Vol. 8, Iss. 21
Open Access | Times Cited: 3

Humoral and cellular immunity to SARS-CoV-2 following vaccination with non-mRNA vaccines in adolescent/young adults with cancer: A prospective cohort study
Archana Sasi, Jyotsna Dandotiya, Jyotsana Kaushal, et al.
Vaccine (2024) Vol. 42, Iss. 10, pp. 2722-2728
Closed Access

Understanding the landscape of the SARS‐CoV‐2‐specific T cells post‐omicron surge
Akshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Closed Access

QuantiFERON SARS-CoV-2 assay for the evaluation of cellular immunity after immunization with mRNA SARS-CoV-2 vaccines: a systematic review and meta-analysis
Maria-Myrto Dourdouna, Georgia Kourlaba, Athanasios Michos
Immunologic Research (2024) Vol. 73, Iss. 1
Closed Access

Multiparametric analysis of the specific immune response against SARS-CoV-2
Lucie Vránová, Ingrid Poláková, Šárka Vaníková, et al.
Infectious Diseases (2024) Vol. 56, Iss. 10, pp. 851-869
Open Access

The Antiviral Mechanism of Action of Molnupiravir in Humans with COVID-19
Timothy P. Sheahan, Laura J. Stevens, Tara M. Narowski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Page 1

Scroll to top